all report title image
  • Published On : Nov 2022
  • Code : CMI5325
  • Industry : Pharmaceutical
  • Pages : 170
  • Formats :

The global antibiotics market was valued at US$ 49,081.2 Mn in 2021 and is forecast to reach a value of US$ 67,874.0 Mn by 2028 at a CAGR of 4.7% between 2022 and 2028. The global antibiotics market is experiencing strong growth unpaid to the high consumption of antibiotics and high prevalence of infectious diseases around the world. Moreover, favorable government initiatives and growing geriatric population across the globe is expected to boost the growth of the market. However, rise in incidence of antibiotic resistance and high cost of trials & research and stringent approval framework are major factors expected to hamper growth of the global antibiotics market over the forecast period.

Global Antibiotics Market: Regional Insights

Based on geography, the global antibiotics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the rising incidence of infectious diseases and growing healthcare expenditure by government in the region. Antibiotics are used to fight bacterial infections. They either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. For instance, the U.S. government is undertaking various measures to control infectious diseases, such as antibiotic stewardship initiatives and R&D activities.

Asia Pacific is also expected to witness robust growth in the global antibiotics market due to the rise in prevalence of infectious diseases, rising consumption of antibiotics, and favorable government initiatives in the region. For instance, antibiotics are widely used to prevent and treat bacterial infections. Used properly, antibiotics can save lives. India has emerged as one of the world's largest consumer of antibiotics. As per the National Center for Biotechnology Information (NCBI), India is the world's fourth largest consumer of antimicrobials for animal use, after China, U.S., and Brazil.

Figure 1. Global Antibiotics Market Share (%), by Region, 2021

Antibiotics  | Coherent Market Insights

Global Antibiotics Market Drivers:

High consumption of antibiotics across the globe is expected to augment growth of the global antibiotics market during the forecast period. For instance, antibiotics are medicines that fight bacterial infections in people and animals. They kill bacteria or prevent them from reproducing and spreading, and thus, there is an increase in demand for antibiotics worldwide. According to the new research conducted by the Lancet Regional Health-Southeast Asia in September 2022, Azithromycin 500mg tablet was the most consumed antibiotic formulation (7.6%) in India, followed by cefixime 200 mg tablet (6.5%).

Rising prevalence of infectious diseases around the world is expected to propel the growth of the global antibiotics market during the forecast period. For instance, antibiotics are powerful medicines that fight bacterial infections. Antibiotics are used to treat or prevent some types of bacterial infections. As per the Centers for Disease Control and Prevention (CDC), in 2020, around 7,174 new cases of tuberculosis (TB) were reported in the United States. Moreover, the common cold affects millions of people in the U.S. every year.

Global Antibiotics Market Opportunities:

Favorable government initiatives for the development of novel therapies are expected to offer significant growth opportunities for players in the antibiotics market. For instance, supportive government legislation such as the REVAMP Act and GAIN Act is expected to accelerate the process of approval, worldwide. The U.S. Food and Drug Administration (FDA) approved four new antibiotic drugs in the second half of 2019.

Growing geriatric population worldwide is expected to offer lucrative growth opportunities for players in the global antibiotics market. For instance, with the growing aging population, the burden of infectious diseases is also increasing with a rapid pace across the globe. This in turn is expected to increase the demand for antibiotics worldwide. According to the United Nations, 2019 report, there are 703 million people aged 65 or older, a number that is expected to reach around 1.5 billion by 2050.

CMI table icon

Antibiotics Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 49,081.2 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 4.7% 2028 Value Projection: US$ 67,874.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Products: Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides,  Aminoglycosides, Other Products
  • By Spectrum: Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics
Companies covered:

Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.

Growth Drivers:
  • High consumption of antibiotics across the globe
  • Rising prevalence of infectious diseases around the world
Restraints & Challenges:
  • Rise in incidence of antibiotic resistance
  • High cost of trials and research and stringent approval framework

Global Antibiotics Market Trends:

The recent trend in the global antibiotics market is the increase in development of safe, effective antibiotics owing to increase in consumption of antibiotics and rise in prevalence of infectious diseases across the globe. With the rising burden in almost every country, the consumption of antibiotics is also increasing rapidly. As a result, market players are focusing on developing and launching safe and effective antibiotics to meet increasing demand. This trend is expected to continue over the forecast period, driving the market growth.

Moreover, there is an increase in demand for newer generation of antibiotics due to increase in resistance to antibiotics, and increase in microbial resistance to antibiotics has become a major global public concern. Thus, there is an increase in demand for newer generation of antibiotics around the world. As a result, players in the market are focusing on launching novel antibiotics in the market, and this trend is expected to continue during the forecast period.

Global Antibiotics Market Restraints:

Rise in incidence of antibiotic resistance is expected to hamper growth of the global antibiotics market. For instance, antibiotic resistance is a serious public health problem. It occurs when bacteria develop the ability to survive exposure to antibiotics designed to kill them or prevent their growth. Moreover, it results in longer hospital stays, higher medical costs, and increased mortality. This in turn is expected to hinder growth of the market.

High cost of trials and research and stringent approval​ framework is expected to hinder growth of the global antibiotics market. For instance, the U.S. Food and Drug Administration (FDA) has increased the fee for Abbreviated New Drug Approval (ANDA) by around US$ 100,000 to 170,000 for the fiscal year of 2018. The hike was approved as per the Generic Drug User Fee Amendments of 2017 (GDUFA II).

Figure 2. Global Antibiotics Market Share (%), by Product Type, 2021

Antibiotics  | Coherent Market Insights

Global Antibiotics Market Segmentation:

The global antibiotics market report is segmented into Product, Spectrum, and Geography.

Based on Product, the market is segmented into Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides, Aminoglycosides, and Other Products. Of which, Penicillins Segment is expected to dominate the antibiotics market during the forecast period and this is attributed to the high consumption of Penicillins. Penicillin is a medication used to manage and treat a wide range of infections.

Cephalosporins Segment is also expected to witness significant growth in the near future and this is owing to the high consumption of Cephalosporin (after Penicillin). Cephalosporins are used to manage a wide range of infections from gram-positive and gram-negative bacteria.

Based on Spectrum, the antibiotics market is segmented into Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics. Of which, Broad-Spectrum Antibiotics Segment is expected to dominate the market over the forecast period and this is attributed to the rising prevalence of infectious diseases around the world. Broad-spectrum antibiotics used to manage both gram-positive and gram-negative bacteria. Most of the doctors prescribe broad-spectrum antibiotics, as they cover a range of bacteria.

Global Antibiotics Market: Key Developments

In October 2021, Sandoz acquired GSK's cephalosporin antibiotics business. It now has the rights to three well-known brands (Zinnat, Zinacef, and Fortum) in 100 markets, strengthening its position as the world's leading antibiotics company.

In July 2019, Nosopharm and Evotec AG teamed up to develop NOSO-502. It is a first-in-class novel antibiotic against Enterobacteriaceae infections. The drug inhibits bacterial ribosome to treat nosocomial infections using polymyxin and carbapenem-resistant Enterobacteriaceae.

Global Antibiotics Market: Key Companies Insights

The global antibiotics market is highly competitive. This is attributed to the rise in demand for antibiotics and rise in consumption of antibiotics, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global antibiotics market are Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.

*Definition: Antibiotics are medicines that fight bacterial infections in people and animals. These drugs help destroy or slow down the growth of bacteria. Antibiotics either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. When used properly, antibiotics can save lives.

Antibiotics are medicines that fight bacterial infections in people and animals. These drugs help destroy or slow down the growth of bacteria. Antibiotics either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. When used properly, antibiotics can save lives. Thus, there is an increase in demand for antibiotics worldwide.

Market Dynamics:

Rising prevalence of bacterial infections, high consumption of antibiotics, need for effective and newer antibiotics, growing geriatric population, and favorable government initiatives are major factors expected to aid in the growth of the global antibiotics market. For instance, in March 2019, Global Antibiotic Research and Development Partnership (GARDP) announced a public-private partnership with Evotec AG for the development of first-in-class antibiotics for treating drug-resistant bacterial infections.

Moreover, in August 2019, the U.S. Food and Drug Administration (FDA) approved Xenleta (lefamulin), a new antibiotic to treat adults with community-acquired bacterial pneumonia. The new antibiotic provides another option for the treatment of patients with community-acquired bacterial pneumonia, a serious disease

Key features of the study:

  • This report provides in-depth analysis of the global antibiotics market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global antibiotics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotics market.

Detailed Segmentation:

  • Global Antibiotics Market By Products:
    • Cephalosporins
    • Penicillins
    • Fluroquinilones
    • Macrolides
    • Carbapenems
    • Sulfonamides
    • Aminoglycosides
    • Other Products
  • Global Antibiotics Market By Spectrum:
    • Broad-Spectrum Antibiotics
    • Narrow-Spectrum Antibiotics
  • Global Antibiotics Market By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Roche Holding AG
    • Abbott Laboratories
    • Sanofi SA
    • Novartis AG
    • AstraZeneca
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Johnson & Johnson
    • GlaxoSmithKline
    • Bayer Healthcare AG

Frequently Asked Questions

The global antibiotics market size is estimated to be valued at US$ 51,378.2 Million in 2022 and is expected to exhibit a CAGR of 4.7% between 2022 and 2028.
High consumption of antibiotics and rising prevalence of infectious diseases around the world is fueling the market.
The Cephalosporin segment is the leading product type segment in the market.
Major players operating in the market are Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.
Rise in incidence of antibiotic resistance and high cost of trials and research and stringent approval framework are major factors restraining growth of the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo